Qiming, Hillhouse-backed biotech firm Jacobio raises $174m in HK IPO

Qiming, Hillhouse-backed biotech firm Jacobio raises $174m in HK IPO

Laboratory equipment. Photo: Pixabay

Jacobio Pharmaceuticals Group, a Chinese clinical-stage pharmaceutical firm focusing on oncology therapies, has raised about HK$1.35 billion ($174.1 million) in an initial public offering (IPO) on the main board of the Stock Exchange of Hong Kong on Monday.